scholarly journals Effects of long-term in vivo micro-CT imaging on hallmarks of osteopenia and frailty in aging mice

PLoS ONE ◽  
2020 ◽  
Vol 15 (9) ◽  
pp. e0239534
Author(s):  
Ariane C. Scheuren ◽  
Gisela A. Kuhn ◽  
Ralph Müller
Keyword(s):  
2020 ◽  
Author(s):  
Ariane C. Scheuren ◽  
Gisela A. Kuhn ◽  
Ralph Müller

AbstractIn vivo micro-CT has already been used to monitor microstructural changes of bone in mice of different ages and in models of age-related diseases such as osteoporosis. However, as aging is accompanied by frailty and subsequent increased sensitivity to external stimuli such as handling and anesthesia, the extent to which longitudinal imaging can be applied in aging studies remains unclear. Consequently, the potential of monitoring individual mice during the entire aging process – from healthy to frail status – has not yet been exploited. In this study, we assessed the effects of long-term in vivo micro-CT imaging - consisting of 11 imaging sessions over 20 weeks - on hallmarks of aging both on a local (i.e., static and dynamic bone morphometry) and systemic (i.e., frailty index (FI) and body weight) level at various stages of the aging process. Furthermore, using a premature aging model (PolgA(D257A/D257A)), we assessed whether these effects differ between genotypes.The 6th caudal vertebrae of 4 groups of mice (PolgA(D257A/D257A) and PolgA(+/+)) were monitored by in vivo micro-CT every 2 weeks. One group was subjected to 11 scans between weeks 20 and 40 of age, whereas the other groups were subjected to 5 scans between weeks 26-34, 32-40 and 40-46, respectively. The long-term monitoring approach showed small but significant changes in the static bone morphometric parameters compared to the other groups. However, no interaction effect between groups and genotype was found, suggesting that PolgA mutation does not render bone more or less susceptible to long-term micro-CT imaging. The differences between groups observed in the static morphometric parameters were less pronounced in the dynamic morphometric parameters. Moreover, the body weight and FI were not affected by more frequent imaging sessions. Finally, we observed that longitudinal designs including baseline measurements at young adult age are more powerful at detecting effects of in vivo micro-CT imaging on hallmarks of aging than cross-sectional comparisons between multiple groups of aged mice subjected to fewer imaging sessions.


2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e20557-e20557
Author(s):  
Tao Li ◽  
Chuan Yang ◽  
Guojun Zhang ◽  
Jianming Huang ◽  
Jiahua Lv ◽  
...  

2010 ◽  
Vol 37 (9) ◽  
pp. 4793-4805 ◽  
Author(s):  
Eman Namati ◽  
Jacqueline Thiesse ◽  
Jessica C. Sieren ◽  
Alan Ross ◽  
Eric A. Hoffman ◽  
...  

2021 ◽  
Author(s):  
Rossana Terracciano ◽  
Aobo Zang ◽  
E. Brian Butler ◽  
Danilo Demarchi ◽  
Jason Hafner ◽  
...  

2009 ◽  
Vol 458 (1) ◽  
pp. 28-31 ◽  
Author(s):  
Tobias Engelhorn ◽  
Ilker Y. Eyupoglu ◽  
Marc A. Schwarz ◽  
Marek Karolczak ◽  
Holger Bruenner ◽  
...  
Keyword(s):  
Micro Ct ◽  

2016 ◽  
Vol 27 (3) ◽  
pp. 1604213 ◽  
Author(s):  
Taeho Kim ◽  
Nohyun Lee ◽  
Dian R. Arifin ◽  
Irina Shats ◽  
Miroslaw Janowski ◽  
...  

2006 ◽  
Author(s):  
Eman Namati ◽  
Deokiee Chon ◽  
Jacqueline Thiesse ◽  
Geoffrey McLennan ◽  
Jered Sieren ◽  
...  

2004 ◽  
Vol 3 (1) ◽  
pp. 153535002004031 ◽  
Author(s):  
Dawn Cavanaugh ◽  
Evan Johnson ◽  
Roger E. Price ◽  
Jonathan Kurie ◽  
Elizabeth L. Travis ◽  
...  
Keyword(s):  

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Mi Huang ◽  
Ying Wang ◽  
Rui Peng

Purpose. Glucocorticoid (GC) is the most important risk factor for osteoporosis (OP); in the present study, we examined the potential mechanism of icariin, a natural bioactive compound isolated from the traditional Chinese herbal Epimedium, for GC-induced OP to explore its potential therapeutic effect. Methods. We used a GC-induced OP mice model and treated with icariin. Pathological changes were measured by H&E staining, and the effects of icariin on osteoblasts and osteoclasts were measured by immunohistochemistry (IHC) staining and western blot (WB) analyses, while trabecular bone parameters were detected by micro-CT imaging in vivo. Results. The results showed that in GC-induced OP symptoms, icariin treatment significantly increased the density of the trabecular bone when exposed to GC, revealed by H&E staining and micro-CT imaging. IHC staining showed that GC-induced OP had a lower EphB4 expression and higher Ephrin-B2 expression, but icariin could promote EphB4 while suppressing Ephrin-B2 expression. The WB results also provided evidence of the same protein expression trend, showing that the osteoblast marker OCN and the EphB4 downstream factor RhoA in the GC group were decreased, while both OCN and RhoA expression were significantly increased and the Ephrin-B2 downstream factor Grb4 in in GC group was increased after icariin treatment. Conclusion. Icariin could improve the characteristics of OP through regulating the balance of the EphB4/Ephrin-B2 pathway. Further preclinical trial is needed to provide certainty of clinical benefits for OP patients.


Sign in / Sign up

Export Citation Format

Share Document